Filing Details
- Accession Number:
- 0001140361-12-025920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-16 21:26:01
- Reporting Period:
- 2012-05-14
- Filing Date:
- 2012-05-16
- Accepted Time:
- 2012-05-16 20:26:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1186678 | A Michael Quinn | Resmed Inc. 9001 Spectrum Center Blvd. San Diego CA 92123 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Resmed Common Stock | Acquisiton | 2012-05-14 | 12,000 | $23.10 | 314,000 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2012-05-14 | 12,000 | $33.30 | 302,000 | No | 4 | S | Direct | |
Resmed Common Stock | Acquisiton | 2012-05-14 | 12,000 | $9.80 | 314,000 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2012-05-14 | 12,000 | $33.26 | 302,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Common Stock | ResMed Common Stock Options | Disposition | 2012-05-14 | 24,000 | $0.00 | 24,000 | $23.10 |
24,000 | ResMed Common Stock Options | Disposition | 2012-05-14 | 24,000 | $0.00 | 24,000 | $9.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-11-10 | 2013-11-10 | No | 4 | M | Direct |
12,000 | 2004-07-07 | 2013-07-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Asx Cdis | 400,000 | Direct | |
Resmed Common Stock | 6,600 | Indirect | Kaylara ATF Straflo Pension Fund |
Footnotes
- Represents date options first became exercisable. Options vest 1/12 per month and are fully vested at one year.
- Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.
- This transaction was executed in multiple trades at prices ranging from $33.26 and 33.31. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
- Previously reported as 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.